Compare PEBO & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PEBO | SLBT |
|---|---|---|
| Founded | 1902 | N/A |
| Country | United States | Taiwan |
| Employees | N/A | 20 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2005 | N/A |
| Metric | PEBO | SLBT |
|---|---|---|
| Price | $41.71 | $2.82 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $37.33 | N/A |
| AVG Volume (30 Days) | ★ 314.0K | 88.0K |
| Earning Date | 04-21-2026 | N/A |
| Dividend Yield | ★ 4.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.59 | N/A |
| Revenue | ★ $197,000.00 | N/A |
| Revenue This Year | $17.29 | N/A |
| Revenue Next Year | $2.97 | N/A |
| P/E Ratio | $26.16 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.49 | $2.54 |
| 52 Week High | $42.29 | $6.25 |
| Indicator | PEBO | SLBT |
|---|---|---|
| Relative Strength Index (RSI) | 68.93 | 39.96 |
| Support Level | $33.72 | $2.54 |
| Resistance Level | $42.29 | $5.10 |
| Average True Range (ATR) | 0.74 | 0.38 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 81.34 | 14.15 |
Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.